Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil and Smoking Cessation for Lung Injury in Smokers
NCT03382106Phase 4Completed
- Start
- Mar 2018
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ASP-001 in emphysema. Started Mar 2018; status: completed.
02
Drugs
ASP-001
03
Conditions
emphysema
Beyond the preview
Go deeper on NCT03382106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03382106.